HK1075654A1 - Hyperforin derivatives, the use thereof and formulations containing them - Google Patents

Hyperforin derivatives, the use thereof and formulations containing them

Info

Publication number
HK1075654A1
HK1075654A1 HK05107783A HK05107783A HK1075654A1 HK 1075654 A1 HK1075654 A1 HK 1075654A1 HK 05107783 A HK05107783 A HK 05107783A HK 05107783 A HK05107783 A HK 05107783A HK 1075654 A1 HK1075654 A1 HK 1075654A1
Authority
HK
Hong Kong
Prior art keywords
formulations containing
hyperforin
hyperforin derivatives
derivatives
adhyperforin
Prior art date
Application number
HK05107783A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Antonella Riva
Nicola Fuzzati
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1075654A1 publication Critical patent/HK1075654A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Lasers (AREA)
HK05107783A 2002-04-23 2005-09-05 Hyperforin derivatives, the use thereof and formulations containing them HK1075654A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000872A ITMI20020872A1 (it) 2002-04-23 2002-04-23 Derivati dell'iperforina loro uso e formulazioni che li contengono
PCT/EP2003/004100 WO2003091194A1 (en) 2002-04-23 2003-04-18 Hyperforin derivatives, the use thereof and formulations containing them

Publications (1)

Publication Number Publication Date
HK1075654A1 true HK1075654A1 (en) 2005-12-23

Family

ID=11449767

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107783A HK1075654A1 (en) 2002-04-23 2005-09-05 Hyperforin derivatives, the use thereof and formulations containing them

Country Status (19)

Country Link
US (2) US7105705B2 (zh)
EP (1) EP1497250B1 (zh)
JP (1) JP4315818B2 (zh)
KR (1) KR100944052B1 (zh)
CN (1) CN1290816C (zh)
AT (1) ATE404519T1 (zh)
CA (1) CA2483205C (zh)
DE (1) DE60322871D1 (zh)
DK (1) DK1497250T3 (zh)
ES (1) ES2311697T3 (zh)
HK (1) HK1075654A1 (zh)
IL (1) IL164763A (zh)
IT (1) ITMI20020872A1 (zh)
NO (1) NO329176B1 (zh)
PL (1) PL205829B1 (zh)
PT (1) PT1497250E (zh)
RU (1) RU2320636C2 (zh)
SI (1) SI1497250T1 (zh)
WO (1) WO2003091194A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772461B (zh) * 2011-05-11 2014-05-14 成都康弘药业集团股份有限公司 药物组合物在制备预防或治疗老年性痴呆的药物中的应用
RU2013157954A (ru) * 2011-06-03 2015-07-20 Президентс Энд Феллоуз Оф Гарвард Колледж Аналоги гиперфорина, способы их синтеза и применения
ITMI20131012A1 (it) 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320091A1 (en) * 1998-02-13 1999-08-19 Dr. Willmar Schwabe Gmbh & Co. Stable hyperforin salts, methods of manufacturing them, and their use for the treatment of alzheimer's disease
WO1999040905A2 (de) 1998-02-13 1999-08-19 Dr. Willmar Schwabe Gmbh & Co. Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
IT1301679B1 (it) 1998-06-10 2000-07-07 Indena Spa Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Also Published As

Publication number Publication date
SI1497250T1 (sl) 2008-12-31
ITMI20020872A0 (it) 2002-04-23
DK1497250T3 (da) 2008-12-01
CA2483205C (en) 2011-07-05
CN1290816C (zh) 2006-12-20
IL164763A (en) 2010-02-17
JP2005523917A (ja) 2005-08-11
ATE404519T1 (de) 2008-08-15
USRE43280E1 (en) 2012-03-27
RU2320636C2 (ru) 2008-03-27
KR100944052B1 (ko) 2010-02-24
PL371347A1 (en) 2005-06-13
NO329176B1 (no) 2010-09-06
KR20040111519A (ko) 2004-12-31
US7105705B2 (en) 2006-09-12
JP4315818B2 (ja) 2009-08-19
US20050165117A1 (en) 2005-07-28
EP1497250A1 (en) 2005-01-19
WO2003091194A1 (en) 2003-11-06
CA2483205A1 (en) 2003-11-06
RU2004131210A (ru) 2005-04-10
CN1646462A (zh) 2005-07-27
AU2003222828A1 (en) 2003-11-10
NO20044519L (no) 2004-11-02
DE60322871D1 (de) 2008-09-25
PT1497250E (pt) 2008-11-12
ITMI20020872A1 (it) 2003-10-23
PL205829B1 (pl) 2010-05-31
EP1497250B1 (en) 2008-08-13
IL164763A0 (en) 2005-12-18
ES2311697T3 (es) 2009-02-16

Similar Documents

Publication Publication Date Title
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
WO2004006858A3 (en) Compounds, compositions, and methods employing same
HK1085667A1 (en) Non-nucleoside reverse transcriptase inhibitors
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MX9708800A (es) Compuestos biciclicos aromaticos.
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
HUP0402526A3 (en) Hydroxylamine derivatives useful in the treatment of vascular diseases, pharmaceutical compositions containing them and use thereof
TW200420560A (en) Crystalline form
ATE334675T1 (de) Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole
GC0000336A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate for the treatment of drug resistant s.pneumoniae

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170418